1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure : the results of the AFFIRM-AHF study
(
- Contribution to journal › Article
- 2020
-
Mark
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial
(
- Contribution to journal › Article